Biomark Med. 2010 Dec;4(6):791.

Backtracking on CYP2C19 genotyping in clopidogrel therapy?

Source

Department of Pathology, University of Texas Southwestern Medical Center and Children's Medical Center, 1935 Medical District Drive, Dallas, TX 75235, USA. jaspar@childrens.com

Comment on

N Engl J Med. 2010 Oct 28;363(18):1704-14.

PMID:: 21133697; [PubMed]

Free full text

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Save items

Related citations in PubMed

Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study. [JACC Cardiovasc Interv. 2010]
Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
Jeong YH, Kim IS, Park Y, Kang MK, Koh JS, Hwang SJ, Kwak CH, Hwang JY. JACC Cardiovasc Interv. 2010 Jul; 3(7):731-41.
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. [JAMA. 2009]
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy.
Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, et al. JAMA. 2009 Aug 26; 302(8):849-57.
Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. [J Am Coll Cardiol. 2010]
Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement.
Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn HP, Büttner HJ, Neumann FJ. J Am Coll Cardiol. 2010 Jun 1; 55(22):2427-34.
Review Genetic causes of clopidogrel nonresponsiveness: which ones really count? [Pharmacotherapy. 2010]
Review Genetic causes of clopidogrel nonresponsiveness: which ones really count?
Momary KM, Dorsch MP, Bates ER. Pharmacotherapy. 2010 Mar; 30(3):265-74.
Review Clopidogrel resistance: pharmacokinetic or pharmacogenetic? [J Clin Pharmacol. 2009]
Review Clopidogrel resistance: pharmacokinetic or pharmacogenetic?
Ford NF. J Clin Pharmacol. 2009 May; 49(5):506-12. Epub 2009 Feb 26.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Backtracking on CYP2C19 genotyping in clopidogrel therapy?
Backtracking on CYP2C19 genotyping in clopidogrel therapy?
Biomark Med. 2010 Dec ;4(6):791.

PubMed
A multicultural assessment of adolescent connectedness: testing measurement inva...
A multicultural assessment of adolescent connectedness: testing measurement invariance across gender and ethnicity.
J Couns Psychol. 2010 Jul ;57(3):274-89.

PubMed
Comparison between the L-DOPA histofluorescence procedure and the indirect immun...
Comparison between the L-DOPA histofluorescence procedure and the indirect immunofluorescence with anti-T6 and -HLA-DR monoclonal antibodies in visualizing Langerhans cells of human epidermis.
Acta Histochem. 1990 ;88(1):59-64.

PubMed
Fluorescence competition and optical melting measurements of RNA three-way multi...
Fluorescence competition and optical melting measurements of RNA three-way multibranch loops provide a revised model for thermodynamic parameters.
Biochemistry. 2011 Feb 8 ;50(5):640-53. Epub 2011 Jan 14 .

PubMed
Variability in response to cryoprecipitate treatment for hemostatic defects in u...
Variability in response to cryoprecipitate treatment for hemostatic defects in uremia.
Yale J Biol Med. 1990 Jan-Feb ;63(1):1-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Backtracking on CYP2C19 genotyping in clopidogrel therapy?

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Other Literature Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information